nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA6—submandibular gland—head and neck cancer	0.146	0.293	CbGeAlD
Brinzolamide—CA6—saliva—head and neck cancer	0.0525	0.105	CbGeAlD
Brinzolamide—CA6—ear—head and neck cancer	0.048	0.0963	CbGeAlD
Brinzolamide—CA6—exocrine gland—head and neck cancer	0.0265	0.0532	CbGeAlD
Brinzolamide—CA6—hair follicle—head and neck cancer	0.0253	0.0507	CbGeAlD
Brinzolamide—CA6—mouth—head and neck cancer	0.0199	0.0398	CbGeAlD
Brinzolamide—Scab—Fluorouracil—head and neck cancer	0.0168	0.0336	CcSEcCtD
Brinzolamide—CA6—parotid gland—head and neck cancer	0.0138	0.0277	CbGeAlD
Brinzolamide—CA6—saliva-secreting gland—head and neck cancer	0.0132	0.0266	CbGeAlD
Brinzolamide—Photopsia—Docetaxel—head and neck cancer	0.0122	0.0242	CcSEcCtD
Brinzolamide—Blepharitis—Hydroxyurea—head and neck cancer	0.0121	0.0241	CcSEcCtD
Brinzolamide—Digestion impaired—Hydroxyurea—head and neck cancer	0.0111	0.0222	CcSEcCtD
Brinzolamide—CA7—trachea—head and neck cancer	0.0105	0.0211	CbGeAlD
Brinzolamide—CA2—exocrine gland—head and neck cancer	0.00914	0.0183	CbGeAlD
Brinzolamide—Lacrimation—Fluorouracil—head and neck cancer	0.00911	0.0182	CcSEcCtD
Brinzolamide—CA2—hair follicle—head and neck cancer	0.00871	0.0175	CbGeAlD
Brinzolamide—Blepharitis—Fluorouracil—head and neck cancer	0.00871	0.0174	CcSEcCtD
Brinzolamide—CA12—connective tissue—head and neck cancer	0.00816	0.0164	CbGeAlD
Brinzolamide—Photophobia—Vinblastine—head and neck cancer	0.00766	0.0153	CcSEcCtD
Brinzolamide—CA6—head—head and neck cancer	0.00717	0.0144	CbGeAlD
Brinzolamide—CA4—neck—head and neck cancer	0.00705	0.0141	CbGeAlD
Brinzolamide—CA12—trachea—head and neck cancer	0.00685	0.0137	CbGeAlD
Brinzolamide—CA2—mouth—head and neck cancer	0.00684	0.0137	CbGeAlD
Brinzolamide—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00676	0.0135	CcSEcCtD
Brinzolamide—Lacrimation—Docetaxel—head and neck cancer	0.00657	0.0131	CcSEcCtD
Brinzolamide—Eye irritation—Fluorouracil—head and neck cancer	0.00627	0.0125	CcSEcCtD
Brinzolamide—CA2—neck—head and neck cancer	0.00584	0.0117	CbGeAlD
Brinzolamide—Lacrimation increased—Fluorouracil—head and neck cancer	0.00581	0.0116	CcSEcCtD
Brinzolamide—CA4—parotid gland—head and neck cancer	0.00574	0.0115	CbGeAlD
Brinzolamide—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00573	0.0114	CcSEcCtD
Brinzolamide—Laryngeal pain—Docetaxel—head and neck cancer	0.00567	0.0113	CcSEcCtD
Brinzolamide—CA4—saliva-secreting gland—head and neck cancer	0.0055	0.011	CbGeAlD
Brinzolamide—Photophobia—Fluorouracil—head and neck cancer	0.00503	0.01	CcSEcCtD
Brinzolamide—Angina pectoris—Vinblastine—head and neck cancer	0.00499	0.00994	CcSEcCtD
Brinzolamide—Oesophagitis—Fluorouracil—head and neck cancer	0.00489	0.00976	CcSEcCtD
Brinzolamide—Breast disorder—Hydroxyurea—head and neck cancer	0.00488	0.00973	CcSEcCtD
Brinzolamide—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00487	0.00971	CcSEcCtD
Brinzolamide—CA5B—thyroid gland—head and neck cancer	0.00486	0.00975	CbGeAlD
Brinzolamide—CA12—head—head and neck cancer	0.00481	0.00964	CbGeAlD
Brinzolamide—Ageusia—Docetaxel—head and neck cancer	0.00477	0.00952	CcSEcCtD
Brinzolamide—Rhinorrhoea—Docetaxel—head and neck cancer	0.00477	0.00952	CcSEcCtD
Brinzolamide—CA2—parotid gland—head and neck cancer	0.00476	0.00955	CbGeAlD
Brinzolamide—CA1—lymphoid tissue—head and neck cancer	0.00473	0.00948	CbGeAlD
Brinzolamide—CA2—saliva-secreting gland—head and neck cancer	0.00456	0.00914	CbGeAlD
Brinzolamide—Depression—Vinblastine—head and neck cancer	0.00455	0.00908	CcSEcCtD
Brinzolamide—Eye irritation—Docetaxel—head and neck cancer	0.00453	0.00903	CcSEcCtD
Brinzolamide—Chest discomfort—Docetaxel—head and neck cancer	0.00437	0.00871	CcSEcCtD
Brinzolamide—CA5B—head—head and neck cancer	0.00431	0.00865	CbGeAlD
Brinzolamide—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00425	0.00848	CcSEcCtD
Brinzolamide—CA4—trachea—head and neck cancer	0.00424	0.00851	CbGeAlD
Brinzolamide—Lacrimation increased—Docetaxel—head and neck cancer	0.0042	0.00837	CcSEcCtD
Brinzolamide—CA2—connective tissue—head and neck cancer	0.00419	0.0084	CbGeAlD
Brinzolamide—Infestation—Hydroxyurea—head and neck cancer	0.00416	0.0083	CcSEcCtD
Brinzolamide—Infestation NOS—Hydroxyurea—head and neck cancer	0.00416	0.0083	CcSEcCtD
Brinzolamide—Amnesia—Fluorouracil—head and neck cancer	0.00414	0.00825	CcSEcCtD
Brinzolamide—Hypoaesthesia—Vinblastine—head and neck cancer	0.00408	0.00813	CcSEcCtD
Brinzolamide—Pharyngitis—Vinblastine—head and neck cancer	0.00407	0.00811	CcSEcCtD
Brinzolamide—CA2—epithelium—head and neck cancer	0.00398	0.00798	CbGeAlD
Brinzolamide—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00394	0.00785	CcSEcCtD
Brinzolamide—Blood pressure increased—Docetaxel—head and neck cancer	0.00387	0.00771	CcSEcCtD
Brinzolamide—CA1—head—head and neck cancer	0.00381	0.00764	CbGeAlD
Brinzolamide—Irritability—Fluorouracil—head and neck cancer	0.00371	0.0074	CcSEcCtD
Brinzolamide—Alopecia—Vinblastine—head and neck cancer	0.00362	0.00722	CcSEcCtD
Brinzolamide—Oesophagitis—Docetaxel—head and neck cancer	0.00353	0.00704	CcSEcCtD
Brinzolamide—CA2—trachea—head and neck cancer	0.00352	0.00705	CbGeAlD
Brinzolamide—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00348	0.00693	CcSEcCtD
Brinzolamide—Angiopathy—Hydroxyurea—head and neck cancer	0.00339	0.00676	CcSEcCtD
Brinzolamide—CA4—thyroid gland—head and neck cancer	0.00335	0.00673	CbGeAlD
Brinzolamide—Ill-defined disorder—Vinblastine—head and neck cancer	0.00331	0.0066	CcSEcCtD
Brinzolamide—Alopecia—Hydroxyurea—head and neck cancer	0.0033	0.00659	CcSEcCtD
Brinzolamide—Angina pectoris—Fluorouracil—head and neck cancer	0.00327	0.00653	CcSEcCtD
Brinzolamide—Erythema—Hydroxyurea—head and neck cancer	0.00325	0.00649	CcSEcCtD
Brinzolamide—Malaise—Vinblastine—head and neck cancer	0.00322	0.00641	CcSEcCtD
Brinzolamide—Vertigo—Vinblastine—head and neck cancer	0.0032	0.00639	CcSEcCtD
Brinzolamide—Hypertension—Vinblastine—head and neck cancer	0.00308	0.00614	CcSEcCtD
Brinzolamide—CA2—lymphoid tissue—head and neck cancer	0.00306	0.00614	CbGeAlD
Brinzolamide—CA5B—lymph node—head and neck cancer	0.00302	0.00606	CbGeAlD
Brinzolamide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00302	0.00602	CcSEcCtD
Brinzolamide—Discomfort—Vinblastine—head and neck cancer	0.003	0.00598	CcSEcCtD
Brinzolamide—Infestation NOS—Fluorouracil—head and neck cancer	0.003	0.00598	CcSEcCtD
Brinzolamide—Infestation—Fluorouracil—head and neck cancer	0.003	0.00598	CcSEcCtD
Brinzolamide—CA4—head—head and neck cancer	0.00298	0.00597	CbGeAlD
Brinzolamide—Visual disturbance—Docetaxel—head and neck cancer	0.00296	0.00591	CcSEcCtD
Brinzolamide—Malaise—Hydroxyurea—head and neck cancer	0.00293	0.00585	CcSEcCtD
Brinzolamide—Conjunctivitis—Fluorouracil—head and neck cancer	0.00291	0.00581	CcSEcCtD
Brinzolamide—Epistaxis—Fluorouracil—head and neck cancer	0.00283	0.00564	CcSEcCtD
Brinzolamide—Sinusitis—Fluorouracil—head and neck cancer	0.00281	0.00561	CcSEcCtD
Brinzolamide—Pain in extremity—Docetaxel—head and neck cancer	0.00281	0.0056	CcSEcCtD
Brinzolamide—CA2—thyroid gland—head and neck cancer	0.00278	0.00558	CbGeAlD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00275	0.00548	CcSEcCtD
Brinzolamide—Discomfort—Hydroxyurea—head and neck cancer	0.00274	0.00546	CcSEcCtD
Brinzolamide—Rhinitis—Fluorouracil—head and neck cancer	0.0027	0.00538	CcSEcCtD
Brinzolamide—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00268	0.00534	CcSEcCtD
Brinzolamide—Pharyngitis—Fluorouracil—head and neck cancer	0.00267	0.00532	CcSEcCtD
Brinzolamide—CA1—lymph node—head and neck cancer	0.00267	0.00535	CbGeAlD
Brinzolamide—Infection—Hydroxyurea—head and neck cancer	0.00264	0.00526	CcSEcCtD
Brinzolamide—Paraesthesia—Vinblastine—head and neck cancer	0.00261	0.00521	CcSEcCtD
Brinzolamide—Nervous system disorder—Hydroxyurea—head and neck cancer	0.0026	0.00519	CcSEcCtD
Brinzolamide—Liver function test abnormal—Docetaxel—head and neck cancer	0.00259	0.00517	CcSEcCtD
Brinzolamide—Skin disorder—Hydroxyurea—head and neck cancer	0.00258	0.00514	CcSEcCtD
Brinzolamide—Abdominal pain upper—Docetaxel—head and neck cancer	0.00256	0.00511	CcSEcCtD
Brinzolamide—Breast disorder—Docetaxel—head and neck cancer	0.00254	0.00506	CcSEcCtD
Brinzolamide—Decreased appetite—Vinblastine—head and neck cancer	0.00253	0.00505	CcSEcCtD
Brinzolamide—Nasopharyngitis—Docetaxel—head and neck cancer	0.00251	0.005	CcSEcCtD
Brinzolamide—Pain—Vinblastine—head and neck cancer	0.00249	0.00496	CcSEcCtD
Brinzolamide—CA2—head—head and neck cancer	0.00247	0.00495	CbGeAlD
Brinzolamide—Arrhythmia—Fluorouracil—head and neck cancer	0.0024	0.00479	CcSEcCtD
Brinzolamide—Feeling abnormal—Vinblastine—head and neck cancer	0.0024	0.00478	CcSEcCtD
Brinzolamide—Alopecia—Fluorouracil—head and neck cancer	0.00238	0.00474	CcSEcCtD
Brinzolamide—Dyspnoea—Hydroxyurea—head and neck cancer	0.00237	0.00472	CcSEcCtD
Brinzolamide—Angina pectoris—Docetaxel—head and neck cancer	0.00236	0.00471	CcSEcCtD
Brinzolamide—Somnolence—Hydroxyurea—head and neck cancer	0.00236	0.00471	CcSEcCtD
Brinzolamide—Erythema—Fluorouracil—head and neck cancer	0.00234	0.00467	CcSEcCtD
Brinzolamide—Dyspepsia—Hydroxyurea—head and neck cancer	0.00234	0.00466	CcSEcCtD
Brinzolamide—Decreased appetite—Hydroxyurea—head and neck cancer	0.00231	0.0046	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00229	0.00457	CcSEcCtD
Brinzolamide—Fatigue—Hydroxyurea—head and neck cancer	0.00229	0.00456	CcSEcCtD
Brinzolamide—Pain—Hydroxyurea—head and neck cancer	0.00227	0.00453	CcSEcCtD
Brinzolamide—Vision blurred—Fluorouracil—head and neck cancer	0.00221	0.0044	CcSEcCtD
Brinzolamide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00219	0.00436	CcSEcCtD
Brinzolamide—Infestation NOS—Docetaxel—head and neck cancer	0.00216	0.00431	CcSEcCtD
Brinzolamide—Infestation—Docetaxel—head and neck cancer	0.00216	0.00431	CcSEcCtD
Brinzolamide—Hypersensitivity—Vinblastine—head and neck cancer	0.00214	0.00428	CcSEcCtD
Brinzolamide—Conjunctivitis—Docetaxel—head and neck cancer	0.0021	0.00419	CcSEcCtD
Brinzolamide—Asthenia—Vinblastine—head and neck cancer	0.00209	0.00417	CcSEcCtD
Brinzolamide—CA4—lymph node—head and neck cancer	0.00208	0.00418	CbGeAlD
Brinzolamide—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00205	0.00408	CcSEcCtD
Brinzolamide—Epistaxis—Docetaxel—head and neck cancer	0.00204	0.00407	CcSEcCtD
Brinzolamide—Chest pain—Fluorouracil—head and neck cancer	0.00199	0.00398	CcSEcCtD
Brinzolamide—Myalgia—Fluorouracil—head and neck cancer	0.00199	0.00398	CcSEcCtD
Brinzolamide—Diarrhoea—Vinblastine—head and neck cancer	0.00199	0.00397	CcSEcCtD
Brinzolamide—Discomfort—Fluorouracil—head and neck cancer	0.00197	0.00393	CcSEcCtD
Brinzolamide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00196	0.0039	CcSEcCtD
Brinzolamide—Rhinitis—Docetaxel—head and neck cancer	0.00195	0.00388	CcSEcCtD
Brinzolamide—Hypoaesthesia—Docetaxel—head and neck cancer	0.00193	0.00385	CcSEcCtD
Brinzolamide—Pharyngitis—Docetaxel—head and neck cancer	0.00193	0.00384	CcSEcCtD
Brinzolamide—Dizziness—Vinblastine—head and neck cancer	0.00193	0.00384	CcSEcCtD
Brinzolamide—Urinary tract disorder—Docetaxel—head and neck cancer	0.00192	0.00382	CcSEcCtD
Brinzolamide—Oedema peripheral—Docetaxel—head and neck cancer	0.00191	0.00381	CcSEcCtD
Brinzolamide—Connective tissue disorder—Docetaxel—head and neck cancer	0.00191	0.0038	CcSEcCtD
Brinzolamide—Asthenia—Hydroxyurea—head and neck cancer	0.0019	0.0038	CcSEcCtD
Brinzolamide—Urethral disorder—Docetaxel—head and neck cancer	0.0019	0.0038	CcSEcCtD
Brinzolamide—Infection—Fluorouracil—head and neck cancer	0.0019	0.00379	CcSEcCtD
Brinzolamide—Nervous system disorder—Fluorouracil—head and neck cancer	0.00187	0.00374	CcSEcCtD
Brinzolamide—Visual impairment—Docetaxel—head and neck cancer	0.00187	0.00373	CcSEcCtD
Brinzolamide—Tachycardia—Fluorouracil—head and neck cancer	0.00187	0.00372	CcSEcCtD
Brinzolamide—Vomiting—Vinblastine—head and neck cancer	0.00185	0.00369	CcSEcCtD
Brinzolamide—Headache—Vinblastine—head and neck cancer	0.00182	0.00364	CcSEcCtD
Brinzolamide—Diarrhoea—Hydroxyurea—head and neck cancer	0.00182	0.00362	CcSEcCtD
Brinzolamide—Eye disorder—Docetaxel—head and neck cancer	0.00181	0.00362	CcSEcCtD
Brinzolamide—Cardiac disorder—Docetaxel—head and neck cancer	0.0018	0.00359	CcSEcCtD
Brinzolamide—Hypotension—Fluorouracil—head and neck cancer	0.00179	0.00356	CcSEcCtD
Brinzolamide—Angiopathy—Docetaxel—head and neck cancer	0.00176	0.00351	CcSEcCtD
Brinzolamide—Dizziness—Hydroxyurea—head and neck cancer	0.00176	0.0035	CcSEcCtD
Brinzolamide—Immune system disorder—Docetaxel—head and neck cancer	0.00175	0.0035	CcSEcCtD
Brinzolamide—Mediastinal disorder—Docetaxel—head and neck cancer	0.00175	0.00349	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00174	0.00347	CcSEcCtD
Brinzolamide—Arrhythmia—Docetaxel—head and neck cancer	0.00173	0.00346	CcSEcCtD
Brinzolamide—Nausea—Vinblastine—head and neck cancer	0.00173	0.00345	CcSEcCtD
Brinzolamide—Insomnia—Fluorouracil—head and neck cancer	0.00173	0.00345	CcSEcCtD
Brinzolamide—CA2—lymph node—head and neck cancer	0.00173	0.00347	CbGeAlD
Brinzolamide—Paraesthesia—Fluorouracil—head and neck cancer	0.00172	0.00342	CcSEcCtD
Brinzolamide—Alopecia—Docetaxel—head and neck cancer	0.00172	0.00342	CcSEcCtD
Brinzolamide—Dyspnoea—Fluorouracil—head and neck cancer	0.0017	0.0034	CcSEcCtD
Brinzolamide—Mental disorder—Docetaxel—head and neck cancer	0.0017	0.00339	CcSEcCtD
Brinzolamide—Somnolence—Fluorouracil—head and neck cancer	0.0017	0.00339	CcSEcCtD
Brinzolamide—Malnutrition—Docetaxel—head and neck cancer	0.00169	0.00337	CcSEcCtD
Brinzolamide—Erythema—Docetaxel—head and neck cancer	0.00169	0.00337	CcSEcCtD
Brinzolamide—Vomiting—Hydroxyurea—head and neck cancer	0.00169	0.00337	CcSEcCtD
Brinzolamide—Dyspepsia—Fluorouracil—head and neck cancer	0.00168	0.00335	CcSEcCtD
Brinzolamide—Rash—Hydroxyurea—head and neck cancer	0.00167	0.00334	CcSEcCtD
Brinzolamide—Dermatitis—Hydroxyurea—head and neck cancer	0.00167	0.00334	CcSEcCtD
Brinzolamide—Headache—Hydroxyurea—head and neck cancer	0.00166	0.00332	CcSEcCtD
Brinzolamide—Decreased appetite—Fluorouracil—head and neck cancer	0.00166	0.00331	CcSEcCtD
Brinzolamide—Dysgeusia—Docetaxel—head and neck cancer	0.00165	0.0033	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00165	0.00329	CcSEcCtD
Brinzolamide—Back pain—Docetaxel—head and neck cancer	0.00163	0.00326	CcSEcCtD
Brinzolamide—Pain—Fluorouracil—head and neck cancer	0.00163	0.00326	CcSEcCtD
Brinzolamide—Muscle spasms—Docetaxel—head and neck cancer	0.00162	0.00324	CcSEcCtD
Brinzolamide—Nausea—Hydroxyurea—head and neck cancer	0.00158	0.00314	CcSEcCtD
Brinzolamide—Feeling abnormal—Fluorouracil—head and neck cancer	0.00157	0.00314	CcSEcCtD
Brinzolamide—Urticaria—Fluorouracil—head and neck cancer	0.00152	0.00303	CcSEcCtD
Brinzolamide—Palpitations—Docetaxel—head and neck cancer	0.00149	0.00298	CcSEcCtD
Brinzolamide—Cough—Docetaxel—head and neck cancer	0.00147	0.00294	CcSEcCtD
Brinzolamide—Hypertension—Docetaxel—head and neck cancer	0.00146	0.00291	CcSEcCtD
Brinzolamide—Arthralgia—Docetaxel—head and neck cancer	0.00144	0.00287	CcSEcCtD
Brinzolamide—Chest pain—Docetaxel—head and neck cancer	0.00144	0.00287	CcSEcCtD
Brinzolamide—Myalgia—Docetaxel—head and neck cancer	0.00144	0.00287	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00143	0.00285	CcSEcCtD
Brinzolamide—Hypersensitivity—Fluorouracil—head and neck cancer	0.00141	0.00281	CcSEcCtD
Brinzolamide—Dry mouth—Docetaxel—head and neck cancer	0.00141	0.00281	CcSEcCtD
Brinzolamide—Infection—Docetaxel—head and neck cancer	0.00137	0.00273	CcSEcCtD
Brinzolamide—Nervous system disorder—Docetaxel—head and neck cancer	0.00135	0.0027	CcSEcCtD
Brinzolamide—Pruritus—Fluorouracil—head and neck cancer	0.00135	0.0027	CcSEcCtD
Brinzolamide—Tachycardia—Docetaxel—head and neck cancer	0.00135	0.00268	CcSEcCtD
Brinzolamide—Skin disorder—Docetaxel—head and neck cancer	0.00134	0.00267	CcSEcCtD
Brinzolamide—Diarrhoea—Fluorouracil—head and neck cancer	0.00131	0.00261	CcSEcCtD
Brinzolamide—Hypotension—Docetaxel—head and neck cancer	0.00129	0.00257	CcSEcCtD
Brinzolamide—Dizziness—Fluorouracil—head and neck cancer	0.00126	0.00252	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00126	0.00251	CcSEcCtD
Brinzolamide—Insomnia—Docetaxel—head and neck cancer	0.00125	0.00249	CcSEcCtD
Brinzolamide—Paraesthesia—Docetaxel—head and neck cancer	0.00124	0.00247	CcSEcCtD
Brinzolamide—Dyspnoea—Docetaxel—head and neck cancer	0.00123	0.00245	CcSEcCtD
Brinzolamide—Somnolence—Docetaxel—head and neck cancer	0.00123	0.00245	CcSEcCtD
Brinzolamide—Vomiting—Fluorouracil—head and neck cancer	0.00122	0.00242	CcSEcCtD
Brinzolamide—Dyspepsia—Docetaxel—head and neck cancer	0.00121	0.00242	CcSEcCtD
Brinzolamide—Rash—Fluorouracil—head and neck cancer	0.0012	0.0024	CcSEcCtD
Brinzolamide—Dermatitis—Fluorouracil—head and neck cancer	0.0012	0.0024	CcSEcCtD
Brinzolamide—Decreased appetite—Docetaxel—head and neck cancer	0.0012	0.00239	CcSEcCtD
Brinzolamide—Headache—Fluorouracil—head and neck cancer	0.0012	0.00239	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00119	0.00237	CcSEcCtD
Brinzolamide—Fatigue—Docetaxel—head and neck cancer	0.00119	0.00237	CcSEcCtD
Brinzolamide—Pain—Docetaxel—head and neck cancer	0.00118	0.00235	CcSEcCtD
Brinzolamide—Feeling abnormal—Docetaxel—head and neck cancer	0.00114	0.00227	CcSEcCtD
Brinzolamide—Nausea—Fluorouracil—head and neck cancer	0.00114	0.00226	CcSEcCtD
Brinzolamide—Hypersensitivity—Docetaxel—head and neck cancer	0.00102	0.00203	CcSEcCtD
Brinzolamide—Asthenia—Docetaxel—head and neck cancer	0.00099	0.00197	CcSEcCtD
Brinzolamide—Pruritus—Docetaxel—head and neck cancer	0.000976	0.00195	CcSEcCtD
Brinzolamide—Diarrhoea—Docetaxel—head and neck cancer	0.000944	0.00188	CcSEcCtD
Brinzolamide—Dizziness—Docetaxel—head and neck cancer	0.000912	0.00182	CcSEcCtD
Brinzolamide—Vomiting—Docetaxel—head and neck cancer	0.000877	0.00175	CcSEcCtD
Brinzolamide—Rash—Docetaxel—head and neck cancer	0.00087	0.00173	CcSEcCtD
Brinzolamide—Dermatitis—Docetaxel—head and neck cancer	0.000869	0.00173	CcSEcCtD
Brinzolamide—Headache—Docetaxel—head and neck cancer	0.000864	0.00172	CcSEcCtD
Brinzolamide—Nausea—Docetaxel—head and neck cancer	0.000819	0.00163	CcSEcCtD
